+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Deslanoside Market by Formulation, Product Type, End User, Distribution Channel, Application - Global Forecast to 2030- Product Image
Deslanoside Market by Formulation, Product Type, End User, Distribution Channel, Application - Global Forecast to 2030- Product Image
Sale

Deslanoside Market by Formulation, Product Type, End User, Distribution Channel, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083212
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Deslanoside market is evolving rapidly, shaped by changing clinical practices and increased demand for advanced cardiovascular therapies. Senior leaders need clear, evidence-based insights to navigate transformation across the pharmaceutical value chain, anticipate regulatory shifts, and seize emerging opportunities in this dynamic sector.

Market Snapshot: Deslanoside Market Size and Growth

The Deslanoside market grew from USD 99.56 billion in 2024 to USD 105.54 billion in 2025. It is expected to continue growing at a CAGR of 5.90%, reaching USD 140.43 billion by 2030. This continued expansion reflects strong clinical demand, ongoing therapeutic innovation, and adaptive strategies by leading manufacturers.

Scope & Segmentation: Understanding Key Market Layers

This report delivers a comprehensive Deslanoside market analysis across multiple strategic segments and regions, helping stakeholders align business strategies with evolving patient needs and healthcare infrastructures:

  • Formulation Types: Injectable (including IM and IV) and Oral formulations support acute care and outpatient management models.
  • Product Types: Brand and Generic offerings highlight the balance between clinical support infrastructure and affordability goals.
  • End Users: Target audiences include Ambulatory Centers, Clinics, and Hospitals—each reflecting unique workflow integration needs and therapy adoption rates.
  • Distribution Channels: Access strategies span Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy channels, allowing for broad and tailored market coverage.
  • Applications: Core clinical uses include Atrial Fibrillation, Congestive Heart Failure, and Supraventricular Tachycardia, supporting both acute intervention and chronic management.
  • Regions: Coverage includes the Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including key EU and Gulf states), and Asia-Pacific (such as China, India, Japan, Australia, and more).
  • Company Benchmarking: Major players analyzed include Teva Pharmaceutical Industries, Sandoz International, Dr. Reddy’s Laboratories, Aurobindo Pharma, Sun Pharmaceutical, Cipla, Lonza Group, Thermo Fisher Scientific, Cambrex, and Recipharm AB.

Key Takeaways for Decision-Makers

  • Deslanoside is reinforced as a critical agent in contemporary cardiac care, with digital health tools enhancing adherence and patient outcomes across care settings.
  • Heightened regulatory scrutiny and evolving safety protocols require manufacturers to maintain robust pharmacovigilance and ensure labeling reflects nuanced risk-benefit profiles.
  • Market competition is intensifying due to the entry of biosimilars and generics, prompting strategic investment in cost-effective manufacturing, real-world evidence generation, and differentiated patient support programs.
  • Technological advances in analytics and drug delivery are enabling custom dosing and monitoring, vital for populations with comorbidities or polypharmacy needs.
  • Sustainable production practices and nearshoring are becoming core strategies to ensure supply chain resilience and compliance with environmental targets.
  • Tailored regional approaches, sensitive to healthcare infrastructure and reimbursement variance, are essential for maximizing penetration and accelerating access to both branded and generic therapies.

Tariff Impact: Regulatory and Supply Chain Dynamics

The introduction of new US tariffs on pharmaceutical raw materials and components in 2025 is expected to affect Deslanoside supply chains by increasing costs throughout manufacturing and distribution. To address these pressures, manufacturers are diversifying sourcing, exploring domestic partnerships, and investing in scenario planning. Proactive management of these trade-related risks will be essential to maintain competitive pricing and uninterrupted market access.

Methodology & Data Sources

Findings draw from primary interviews with cardiology leaders, pharmacists, regulatory specialists, and supply chain executives. This was complemented by a thorough review of peer-reviewed literature, regulatory filings, clinical trial databases, and verified industry publications. Scenario analysis and data triangulation ensure comprehensive and reliable insights throughout the report.

Why This Report Matters

  • Delivers actionable guidance for executive teams to anticipate clinical, regulatory, and operational trends impacting the Deslanoside market landscape.
  • Enables informed portfolio, sourcing, and regional expansion decisions by providing granular segmentation and competitive benchmarking across modalities, channels, and geographies.
  • Supports risk mitigation and innovation with evidence-based analysis of supply chain, technology integration, and tariff-driven challenges.

Conclusion

Senior decision-makers will find targeted, strategic direction to navigate the evolving Deslanoside pharmaceutical market. This report provides a reliable foundation to inform product strategy, operational planning, and competitive positioning for sustained value creation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Deslanoside Market, by Formulation
8.1. Introduction
8.2. Injectable
8.2.1. IM Injection
8.2.2. IV Injection
8.3. Oral
9. Deslanoside Market, by Product Type
9.1. Introduction
9.2. Brand
9.3. Generic
10. Deslanoside Market, by End User
10.1. Introduction
10.2. Ambulatory Centers
10.3. Clinics
10.4. Hospitals
11. Deslanoside Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Deslanoside Market, by Application
12.1. Introduction
12.2. Atrial Fibrillation
12.3. Congestive Heart Failure
12.4. Supraventricular Tachycardia
13. Americas Deslanoside Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Deslanoside Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Deslanoside Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Sandoz International GmbH
16.3.3. Dr. Reddy's Laboratories Ltd.
16.3.4. Aurobindo Pharma Ltd.
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Cipla Limited
16.3.7. Lonza Group AG
16.3.8. Thermo Fisher Scientific Inc.
16.3.9. Cambrex Corporation
16.3.10. Recipharm AB
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DESLANOSIDE MARKET MULTI-CURRENCY
FIGURE 2. DESLANOSIDE MARKET MULTI-LANGUAGE
FIGURE 3. DESLANOSIDE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DESLANOSIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DESLANOSIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DESLANOSIDE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DESLANOSIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DESLANOSIDE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DESLANOSIDE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DESLANOSIDE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DESLANOSIDE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DESLANOSIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DESLANOSIDE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DESLANOSIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DESLANOSIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DESLANOSIDE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DESLANOSIDE MARKET SIZE, BY IM INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DESLANOSIDE MARKET SIZE, BY IV INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DESLANOSIDE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DESLANOSIDE MARKET SIZE, BY BRAND, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DESLANOSIDE MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DESLANOSIDE MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DESLANOSIDE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DESLANOSIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DESLANOSIDE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DESLANOSIDE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DESLANOSIDE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DESLANOSIDE MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DESLANOSIDE MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DESLANOSIDE MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS DESLANOSIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES DESLANOSIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. CANADA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 43. CANADA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. CANADA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. CANADA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. CANADA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. MEXICO DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. MEXICO DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 73. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 74. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. GERMANY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 79. GERMANY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 80. GERMANY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. GERMANY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. GERMANY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. GERMANY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. FRANCE DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 85. FRANCE DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 86. FRANCE DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. FRANCE DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. FRANCE DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. FRANCE DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. RUSSIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 91. RUSSIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 92. RUSSIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. ITALY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. ITALY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 98. ITALY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. ITALY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ITALY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. ITALY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. SPAIN DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 103. SPAIN DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 104. SPAIN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. SPAIN DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. SPAIN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. SPAIN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 115. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 116. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. DENMARK DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. DENMARK DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 128. DENMARK DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. DENMARK DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. DENMARK DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. QATAR DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 139. QATAR DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 140. QATAR DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. QATAR DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. QATAR DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. QATAR DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 145. FINLAND DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 146. FINLAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. FINLAND DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. FINLAND DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. FINLAND DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. SWEDEN DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 151. SWEDEN DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 152. SWEDEN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. NIGERIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. NIGERIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. EGYPT DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 163. EGYPT DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 164. EGYPT DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. EGYPT DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. EGYPT DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. TURKEY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 169. TURKEY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 170. TURKEY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. TURKEY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. TURKEY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. TURKEY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. ISRAEL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 175. ISRAEL DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. NORWAY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 181. NORWAY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 182. NORWAY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. NORWAY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. NORWAY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. NORWAY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. POLAND DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 187. POLAND DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 188. POLAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. POLAND DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. POLAND DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. POLAND DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. SWITZERLAND DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 193. SWITZERLAND DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 205. CHINA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 206. CHINA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 207. CHINA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. CHINA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. CHINA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. CHINA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. INDIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 212. INDIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 213. INDIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. INDIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. INDIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. INDIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. JAPAN DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 218. JAPAN DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 219. JAPAN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. JAPAN DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. JAPAN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. JAPAN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. THAILAND DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 242. THAILAND DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 243. THAILAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. THAILAND DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. THAILAND DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. THAILAND DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. VIETNAM DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 266. VIETNAM DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. DESLANOSIDE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 278. DESLANOSIDE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Deslanoside market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Dr. Reddy's Laboratories Ltd.
  • Aurobindo Pharma Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • Cambrex Corporation
  • Recipharm AB

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 105.54 Billion
Forecasted Market Value ( USD ) by 2030 $ 140.43 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Deslanoside Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Deslanoside Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Deslanoside (CAS 17598-65-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Deslanoside (CAS 17598-65-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Cyclandelate Market by Product Type, Route Of Administration, Distribution Channel, End User, Application, Dosage Strength - Global Forecast to 2030 - Product Image

Cyclandelate Market by Product Type, Route Of Administration, Distribution Channel, End User, Application, Dosage Strength - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030 - Product Image

Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030

  • Report
  • 125 Pages
  • Global
From

About the Deslanoside Market

Deslanoside is a cardiovascular drug used to treat congestive heart failure and other heart-related conditions. It is a type of cardiac glycoside, a class of drugs that work by increasing the force of contraction of the heart muscle. Deslanoside is used to treat a variety of heart conditions, including atrial fibrillation, ventricular tachycardia, and ventricular fibrillation. It is also used to treat high blood pressure and to reduce the risk of stroke. Deslanoside is available in both oral and injectable forms. Deslanoside is a widely used drug in the cardiovascular market, and is available in many countries around the world. It is generally well tolerated, with few side effects. However, it can interact with other medications, so it is important to discuss any potential interactions with a doctor before taking deslanoside. Some companies in the Deslanoside market include Sanofi, Pfizer, Merck, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.